Get started
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred StockFortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred StockFortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

FBIOP chart


Full chart

FBIOP upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪76.77 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.09 USD
Net income (FY)
‪−46.00 M‬ USD
Revenue (FY)
‪57.67 M‬ USD
Shares float
‪21.26 M‬
Beta (1Y)
1.08

Employees


Employees (FY)
101
Change (1Y)
−85 −45.70%
Revenue / Employee (1Y)
‪571.04 K‬ USD
Net income / Employee (1Y)
‪−455.42 K‬ USD

About Fortress Biotech, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Lindsay Allan Rosenwald
Website
fortressbiotech.com
Headquarters
Bay Harbor Islands
Founded
2006
ISIN
US34960Q2084
FIGI
BBG00J41K534
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Check out other big names from the same industry as FBIOP.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

FBIOP news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of FBIOP is 9.41 USD — it has increased by 1.59% in the past 24 hours. Watch Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stocks are traded under the ticker FBIOP.
FBIOP stock has risen by 9.82% compared to the previous week, the month change is a 12.15% rise, over the last year Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock has showed a 40.24% increase.
FBIOP reached its all-time high on Jul 1, 2021 with the price of 26.69 USD, and its all-time low was 4.72 USD and was reached on Apr 15, 2025. View more price dynamics on FBIOP chart.
See other stocks reaching their highest and lowest prices.
FBIOP stock is 20.00% volatile and has beta coefficient of 1.08. Track Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stock price on the chart and check out the list of the most volatile stocks — is Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock there?
Today Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock has the market capitalization of ‪76.77 M‬, it has increased by 12.66% over the last week.
Yes, you can track Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock financials in yearly and quarterly reports right on TradingView.
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is going to release the next earnings report on Nov 17, 2025. Keep track of upcoming events with our Earnings Calendar.
FBIOP earnings for the last quarter are 0.45 USD per share, whereas the estimation was −0.36 USD resulting in a 225.00% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock earnings.
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock revenue for the last quarter amounts to ‪16.41 M‬ USD, despite the estimated figure of ‪14.53 M‬ USD. In the next quarter, revenue is expected to reach ‪20.64 M‬ USD.
FBIOP net income for the last quarter is ‪15.49 M‬ USD, while the quarter before that showed ‪−10.58 M‬ USD of net income which accounts for 246.32% change. Track more Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock financial stats to get the full picture.
Yes, FBIOP dividends are paid monthly. The last dividend per share was 0.20 USD. As of today, Dividend Yield (TTM)% is 0.00%. Tracking Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock dividends might help you take more informed decisions.
As of Sep 2, 2025, the company has 101 employees. See our rating of the largest employees — is Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock EBITDA is ‪−101.93 M‬ USD, and current EBITDA margin is −180.20%. See more stats in Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock financial statements.
Like other stocks, FBIOP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stock shows the buy signal. See more of Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.